Navigation Links
PharMEDium Unveils Drug Shortage and Usage Updates on New Website with Focus on Patient Safety
Date:8/15/2011

LAKE FOREST, Ill., Aug. 15, 2011 /PRNewswire/ -- PharMEDium Services, LLC, market leader for customized pharmacy sterile compounding for hospital intravenous and epidural therapies, launched its new website, www.pharmedium.com, which now provides updates on drug shortages, patient safety and ready-to-use pharmacy compounding services.  Hospital customers can easily obtain valuable information on PharMEDium's broad range of services designed to reduce waste, improve efficiency and enhance patient safety. The PharMEDium website design provides information necessary to facilitate a hospital's selection of the right partner for compounded sterile preparations and demonstrates the qualities to look for when assessing a possible outsourced pharmacy sterile compounding service provider.  The result of choosing a partner that ranks high in regulatory compliance, quality and patient safety measures, medication administration safety features and service excellence is the selection of a reputable and reliable outsourced pharmacy sterile compounding service provider.  

Amy Langan, VP of Marketing and Business Development, commented, "PharMEDium's new website demonstrates our ongoing commitment to improve on our customer service experience providing innovative customized pharmacy sterile compounding solutions to the market we serve.  We conducted extensive customer research to ensure that our website design and development met the mark for enhancing patient safety.  We succeeded by making valuable service information easier to locate, use and refer to at the touch of a key."

PharMEDium hospital customers want easy access to drug shortage information and ready-to-use pharmacy compounding service updates as well as convenient online ordering capability for DEA Schedule II Controlled Substances.  Central to PharMEDium Services is www.pharmedium.com, where convenient online ordering for customers resides.  Online ordering has been propelled to the next generation by the establishment of the Controlled Substance Online System "CSOS" for ordering DEA Schedule II Controlled Substances.

David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation stated, "PharMEDium's launch of an enhanced website experience is yet another example of our commitment to provide hospital customers with continuous service improvements.  Our wide-range of pharmacy compounding services, innovative processes and customer service demonstrates our continued commitment to be the national leader in hospital outsourced compounding services."

PharMEDium is the national leading provider of customized pharmacy sterile compounding for hospital intravenous and epidural therapies. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.


'/>"/>
SOURCE PharMEDium Services, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PharMEDium Services, LLC Receives U.S. Patent 7,918,830 Entitled Safety Device for Drug Delivery Devices and Containers
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia
4. PharMEDium Hires Thomas W. Rasnic as Vice President, Quality, Regulatory Affairs and Research and Development
5. PharMEDium Elects William R. Spalding to Board of Directors
6. Echo Therapeutics Unveils Symphony tCGM Demonstration Video
7. Clearbridge BioLoc Unveils Innovative Lab-on-Card Analysis Platform for Point-of-Care Testing at Worlds Largest Clinical Lab Conference
8. Siemens Unveils Innovation Power for the Clinical Laboratory at 2011 AACC and ASCLS Annual Meetings and Clinical Lab Expo
9. IncellDx CEO Unveils Revolutionary New Tool In The Fight Against Cancer
10. Wellsense Unveils First-Ever Bedside Patient Pressure Mapping System Designed to Assist Caregivers in Effectively Repositioning Patients
11. Omnicell Unveils Largest Ever Medication and Supply Automation Product Launch: the G4 Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the ... save lost souls in the Philippines. “The Journey: From the Mountains to the Mission ... of the Bible. She has taught all ages and currently teaches a class of ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):